Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
GLAXO ZANTAC WORLDWIDE SALES TOP $2.4 BIL. IN FY 1990 ON 8.5% INCREASE, ANTI-ASTHMA PRODUCT SALES GROW 17% TO $1.2 BIL.; SALES IN U.S. JUMP 20% TO $2 BIL.
Oct 01 1990
•
By
The Pink Sheet
More from Archive
More from Pink Sheet